TAVALISSE® (fostamatinib disodium hexahydrate) tablets

  • Home
  • TAVALISSE® (fostamatinib disodium hexahydrate) tablets

TAVALISSE® (fostamatinib disodium hexahydrate) tablets https://www.rigel.com/privacy-policy You’ll also find tips and resources to help you choose a treatment that fits your lifestyle.

We invite you to join a community of people interested in learning more about chronic ITP and exploring a different approach to managing it. If you have been diagnosed with chronic ITP and/or are interested in learning more about the disease and its treatment, please follow our page. Here, you’ll find answers to questions about ITP, as well as information on what to expect during treatment with TA

VALISSE and how TAVALISSE works differently than other chronic ITP treatments. Find out if TAVALISSE may be right for you—like our page, follow us, and visit TAVALISSE.com.

01/09/2023

September is ITP Awareness Month! Join Rigel in helping raise awareness of ITP and showing support for patients and their care providers.

Learn more about managing chronic ITP at https://rebrand.ly/tava-resources

15/11/2022

Taking a holiday trip? Convenient oral dosing together with no dietary restrictions can help you savor the flavor wherever you go. See Important Safety Information and full Prescribing Information: https://rebrand.ly/tavalisse-4

16/08/2022

Working up a sweat? Together with TAVALISSE, you can achieve your ITP treatment goals and stay in your groove. See Important Safety Information and full Prescribing Information: https://rebrand.ly/tavalisse-3

14/06/2022

Enjoying warm weather with friends? Create more enduring memories together while you protect your platelets with TAVALISSE. See Important Safety Information and full Prescribing Information: https://rebrand.ly/tavalisse-2

10/05/2022

Back in the office together? Keep your focus on delivering big results with early response and lasting benefits. See Important Safety Information and full Prescribing Information: https://rebrand.ly/tavalisse-1

22/02/2022

At Rigel, the maker of TAVALISSE, every day is a chance to help people with chronic ITP. See Important Safety Information and Full Prescribing Information: https://rebrand.ly/tavalisse

15/09/2021

Living with ITP can be difficult. During ITP Awareness Month, Rigel is recognizing the strength and courage of people managing chronic ITP. Visit https://rebrand.ly/tava-resources to hear from an expert about ITP and a treatment option that works differently.

02/09/2021

September is ITP Awareness Month! Join Rigel in help raising awareness of ITP and showing support for patients and their care providers.

See Important Safety and full Prescribing Information here: https://rebrand.ly/Tavalisse-PI

25/08/2021

Trouble fitting ITP treatment in with daily activities? Learn about a different approach to managing ITP.

See Important Safety and full Prescribing Information here: https://rebrand.ly/Tavalisse-PI

29/07/2021

TAVALISSE works differently to treat ITP. Hear a patient with ITP talk about success with TAVALISSE after other treatments had not worked well enough.

See Important Safety and full Prescribing Information here: https://rebrand.ly/Tavalisse-PI

20/07/2021

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about TAVALISSE?

TAVALISSE can cause serious side effects including:
• High blood pressure (hypertension). New or worsening high blood pressure is common in people treated with TAVALISSE and can be severe. Your healthcare provider will check your blood pressure regularly during treatment with TAVALISSE. If needed, your healthcare provider may start you on blood pressure medicine or change your current medicine to treat your blood pressure. Tell your healthcare provider if you get headaches, confusion, dizziness, chest pain, or shortness of breath.
• Liver problems. Changes in liver function blood tests are common with TAVALISSE. Liver problems may occur and can be severe. Your healthcare provider will regularly do blood tests to check how well your liver is working during treatment with TAVALISSE.
• Diarrhea. Diarrhea is common in people treated with TAVALISSE and can be severe. Tell your healthcare provider if you get diarrhea during treatment with TAVALISSE. Your healthcare provider may recommend changes in your diet, drinking more water, or medicine to limit these symptoms.
• Decreases in white blood cell count (neutropenia). Decreases in your white blood cell count are common with TAVALISSE and can be severe. This may increase your risk for infection, including serious infections. Your healthcare provider will regularly do blood tests to check your white blood cell counts.
Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with TAVALISSE if you have side effects.
What do I need to discuss with my healthcare provider before taking TAVALISSE?
Before you take TAVALISSE, tell your healthcare provider about all of your medical conditions, including if you:
• have high blood pressure
• have liver problems
• are pregnant or plan to become pregnant. TAVALISSE can harm your unborn baby.
- Your healthcare provider will check if you are pregnant before starting treatment with TAVALISSE.
- Females who can become pregnant should use effective birth control during treatment with TAVALISSE and for at least 1 month after the last dose.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TAVALISSE with certain other medicines may affect how the other medicines work or how TAVALISSE works.
What are the possible side effects of TAVALISSE?
The most common side effects of TAVALISSE include:
• Nausea, rash, dizziness, tiredness, respiratory infection, chest pain, and stomach (abdomen) pain.

These are not all the side effects of TAVALISSE. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA, at 1-800-FDA-1088.

What is TAVALISSE?

TAVALISSE is a prescription medication used to treat adults with low platelet counts due to chronic immune thrombocytopenia (ITP) when a prior treatment for ITP has not worked well enough. It is not known if TAVALISSE is safe and effective in children.

Please see https://rebrand.ly/TAVALISSE for full Prescribing Information and patient information.

Address


Alerts

Be the first to know and let us send you an email when TAVALISSE® (fostamatinib disodium hexahydrate) tablets posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Telephone
  • Alerts
  • Claim ownership or report listing
  • Want your practice to be the top-listed Clinic?

Share